Literature DB >> 31978345

FAMIN Is a Multifunctional Purine Enzyme Enabling the Purine Nucleotide Cycle.

M Zaeem Cader1, Rodrigo Pereira de Almeida Rodrigues1, James A West2, Gavin W Sewell1, Muhammad N Md-Ibrahim1, Stephanie Reikine3, Giuseppe Sirago1, Lukas W Unger1, Ana Belén Iglesias-Romero1, Katharina Ramshorn1, Lea-Maxie Haag1, Svetlana Saveljeva1, Jana-Fabienne Ebel4, Philip Rosenstiel4, Nicole C Kaneider1, James C Lee1, Trevor D Lawley5, Allan Bradley6, Gordon Dougan7, Yorgo Modis3, Julian L Griffin8, Arthur Kaser9.   

Abstract

Mutations in FAMIN cause arthritis and inflammatory bowel disease in early childhood, and a common genetic variant increases the risk for Crohn's disease and leprosy. We developed an unbiased liquid chromatography-mass spectrometry screen for enzymatic activity of this orphan protein. We report that FAMIN phosphorolytically cleaves adenosine into adenine and ribose-1-phosphate. Such activity was considered absent from eukaryotic metabolism. FAMIN and its prokaryotic orthologs additionally have adenosine deaminase, purine nucleoside phosphorylase, and S-methyl-5'-thioadenosine phosphorylase activity, hence, combine activities of the namesake enzymes of central purine metabolism. FAMIN enables in macrophages a purine nucleotide cycle (PNC) between adenosine and inosine monophosphate and adenylosuccinate, which consumes aspartate and releases fumarate in a manner involving fatty acid oxidation and ATP-citrate lyase activity. This macrophage PNC synchronizes mitochondrial activity with glycolysis by balancing electron transfer to mitochondria, thereby supporting glycolytic activity and promoting oxidative phosphorylation and mitochondrial H+ and phosphate recycling.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  C13orf31; Crohn's disease; FAMIN; LACC1; Still's disease; immunometabolism; pH homeostasis; purine metabolism; purine nucleotide cycle; redox homeostasis

Mesh:

Substances:

Year:  2020        PMID: 31978345      PMCID: PMC6978800          DOI: 10.1016/j.cell.2019.12.017

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  74 in total

1.  Crystal structure of hypothetical protein YfiH from Shigella flexneri at 2 A resolution.

Authors:  Youngchang Kim; Natalia Maltseva; Irina Dementieva; Frank Collart; Denise Holzle; Andrzej Joachimiak
Journal:  Proteins       Date:  2006-06-01

2.  MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells.

Authors:  Gregory V Kryukov; Frederick H Wilson; Jason R Ruth; Joshiawa Paulk; Aviad Tsherniak; Sara E Marlow; Francisca Vazquez; Barbara A Weir; Mark E Fitzgerald; Minoru Tanaka; Craig M Bielski; Justin M Scott; Courtney Dennis; Glenn S Cowley; Jesse S Boehm; David E Root; Todd R Golub; Clary B Clish; James E Bradner; William C Hahn; Levi A Garraway
Journal:  Science       Date:  2016-02-11       Impact factor: 47.728

Review 3.  The biological significance of purine salvage.

Authors:  A W Murray
Journal:  Annu Rev Biochem       Date:  1971       Impact factor: 23.643

Review 4.  Ammonia production in muscle and other tissues: the purine nucleotide cycle.

Authors:  J M Lowenstein
Journal:  Physiol Rev       Date:  1972-04       Impact factor: 37.312

5.  Identification of a new fatty acid synthesis-transport machinery at the peroxisomal membrane.

Authors:  Merle Hillebrand; Søren W Gersting; Amelie S Lotz-Havla; Annika Schäfer; Hendrik Rosewich; Oliver Valerius; Ania C Muntau; Jutta Gärtner
Journal:  J Biol Chem       Date:  2011-11-01       Impact factor: 5.157

Review 6.  Purine nucleoside phosphorylases: properties, functions, and clinical aspects.

Authors:  A Bzowska; E Kulikowska; D Shugar
Journal:  Pharmacol Ther       Date:  2000-12       Impact factor: 12.310

7.  Identification of the antimetabolite of L-alanosine, L-alanosyl-5-amino-4-imidazolecarboxylic acid ribonucleotide, in tumors and assessment of its inhibition of adenylosuccinate synthetase.

Authors:  A K Tyagi; D A Cooney
Journal:  Cancer Res       Date:  1980-12       Impact factor: 12.701

8.  C13orf31 (FAMIN) is a central regulator of immunometabolic function.

Authors:  M Zaeem Cader; Katharina Boroviak; Qifeng Zhang; Ghazaleh Assadi; Sarah L Kempster; Gavin W Sewell; Svetlana Saveljeva; Jonathan W Ashcroft; Simon Clare; Subhankar Mukhopadhyay; Karen P Brown; Markus Tschurtschenthaler; Tim Raine; Brendan Doe; Edwin R Chilvers; Jules L Griffin; Nicole C Kaneider; R Andres Floto; Mauro D'Amato; Allan Bradley; Michael J O Wakelam; Gordon Dougan; Arthur Kaser
Journal:  Nat Immunol       Date:  2016-08-01       Impact factor: 25.606

9.  Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS.

Authors:  Edward T Chouchani; Victoria R Pell; Edoardo Gaude; Dunja Aksentijević; Stephanie Y Sundier; Ellen L Robb; Angela Logan; Sergiy M Nadtochiy; Emily N J Ord; Anthony C Smith; Filmon Eyassu; Rachel Shirley; Chou-Hui Hu; Anna J Dare; Andrew M James; Sebastian Rogatti; Richard C Hartley; Simon Eaton; Ana S H Costa; Paul S Brookes; Sean M Davidson; Michael R Duchen; Kourosh Saeb-Parsy; Michael J Shattock; Alan J Robinson; Lorraine M Work; Christian Frezza; Thomas Krieg; Michael P Murphy
Journal:  Nature       Date:  2014-11-05       Impact factor: 49.962

10.  Human LACC1 increases innate receptor-induced responses and a LACC1 disease-risk variant modulates these outcomes.

Authors:  Amit Lahiri; Matija Hedl; Jie Yan; Clara Abraham
Journal:  Nat Commun       Date:  2017-06-08       Impact factor: 14.919

View more
  12 in total

Review 1.  The metabolic nature of inflammatory bowel diseases.

Authors:  Timon E Adolph; Moritz Meyer; Julian Schwärzler; Lisa Mayr; Felix Grabherr; Herbert Tilg
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-07-29       Impact factor: 73.082

2.  A purine metabolic checkpoint that prevents autoimmunity and autoinflammation.

Authors:  Svetlana Saveljeva; Gavin W Sewell; Katharina Ramshorn; M Zaeem Cader; James A West; Simon Clare; Lea-Maxie Haag; Rodrigo Pereira de Almeida Rodrigues; Lukas W Unger; Ana Belén Iglesias-Romero; Lorraine M Holland; Christophe Bourges; Muhammad N Md-Ibrahim; James O Jones; Richard S Blumberg; James C Lee; Nicole C Kaneider; Trevor D Lawley; Allan Bradley; Gordon Dougan; Arthur Kaser
Journal:  Cell Metab       Date:  2022-01-04       Impact factor: 27.287

3.  Therapeutic Effect of Buyang Huanwu Decoction on the Gut Microbiota and Hippocampal Metabolism in a Rat Model of Cerebral Ischemia.

Authors:  Rongmei Tang; Jian Yi; Shuangying Lu; Bowei Chen; Baiyan Liu
Journal:  Front Cell Infect Microbiol       Date:  2022-06-14       Impact factor: 6.073

Review 4.  Interleukin-23 in the Pathogenesis of Inflammatory Bowel Disease and Implications for Therapeutic Intervention.

Authors:  Gavin W Sewell; Arthur Kaser
Journal:  J Crohns Colitis       Date:  2022-05-11       Impact factor: 10.020

Review 5.  Activity-based annotation: the emergence of systems biochemistry.

Authors:  Kyu Y Rhee; Robert S Jansen; Christoph Grundner
Journal:  Trends Biochem Sci       Date:  2022-04-13       Impact factor: 14.264

Review 6.  Purines: From Diagnostic Biomarkers to Therapeutic Agents in Brain Injury.

Authors:  Bruno G Frenguelli; Nicholas Dale
Journal:  Neurosci Bull       Date:  2020-06-15       Impact factor: 5.203

Review 7.  Intestinal epithelial cell metabolism at the interface of microbial dysbiosis and tissue injury.

Authors:  Eva Rath; Dirk Haller
Journal:  Mucosal Immunol       Date:  2022-05-09       Impact factor: 8.701

8.  GABA transporter sustains IL-1β production in macrophages.

Authors:  Yaoyao Xia; Fang He; Xiaoyan Wu; Bie Tan; Siyuan Chen; Yuexia Liao; Ming Qi; Shuai Chen; Yuanyi Peng; Yulong Yin; Wenkai Ren
Journal:  Sci Adv       Date:  2021-04-07       Impact factor: 14.136

9.  LACC1 deficiency links juvenile arthritis with autophagy and metabolism in macrophages.

Authors:  Ommar Omarjee; Anne-Laure Mathieu; Gaëlle Quiniou; Marion Moreews; Michelle Ainouze; Cécile Frachette; Isabelle Melki; Cécile Dumaine; Mathieu Gerfaud-Valentin; Agnès Duquesne; Tilmann Kallinich; Eda Tahir Turanli; Christophe Malcus; Sébastien Viel; Rémi Pescarmona; Sophie Georgin-Lavialle; Yvan Jamilloux; Jean-Paul Larbre; Guillaume Sarrabay; Flora Magnotti; Gillian I Rice; Francoise Bleicher; Jonathan Reboulet; Samir Merabet; Thomas Henry; Yanick J Crow; Mathias Faure; Thierry Walzer; Alexandre Belot
Journal:  J Exp Med       Date:  2021-03-01       Impact factor: 14.307

10.  Nrf2 activation does not affect adenoma development in a mouse model of colorectal cancer.

Authors:  Elena V Knatko; Cecilia Castro; Maureen Higgins; Ying Zhang; Tadashi Honda; Colin J Henderson; C Roland Wolf; Julian L Griffin; Albena T Dinkova-Kostova
Journal:  Commun Biol       Date:  2021-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.